Terns Pharmaceuticals Inc...

NASDAQ: TERN · Real-Time Price · USD
7.07
0.30 (4.43%)
At close: Aug 15, 2025, 3:59 PM
7.12
0.78%
After-hours: Aug 15, 2025, 06:54 PM EDT

Terns Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-24.09M -23.91M -21.8M -21.95M -22.74M -22.37M -21.02M -29.77M -17.9M -21.53M -15.82M -16.82M -13.93M -13.77M -14.25M -11.84M -10.74M -13.34M
Depreciation & Amortization
108K 169K 214K 206K 240K 236K 220K 222K 217K 222K 233K 252K 269K 278K 114K 107K 119K 172K
Stock-Based Compensation
3.03M 3.68M 3.02M 4.16M 4.42M 4.03M 3.28M 14.08M 4.23M 3.94M 2.69M 2.69M 2.65M 2.74M 2.55M 1.85M 1.91M 1.83M
Other Working Capital
n/a -4.93M 4.8M 2.08M 2.26M -3.55M 465K -1.31M -1.45M 2.44M 2.38M -406K 489K -2.77M 41K 1.35M 656K -5.2M
Other Non-Cash Items
2.08M -109K -1.16M -741K -565K 4.95M -1.5M -1.75M -975K -806K -566K -26K 60K 613K 194K 535K 153K -3K
Deferred Income Tax
n/a n/a -79K -68K 34K 34K 45K 32K 32K 32K 353K 14K 4K 21K 174K 7K 22K 16K
Change in Working Capital
n/a -4.3M 5.22M 1.94M 2.43M -4.36M -345K -3.52M 1.4M 3.76M 1.9M 458K -216K -3.18M 547K 1.25M -225K -3M
Operating Cash Flow
-18.88M -24.44M -14.58M -16.45M -16.18M -22.8M -19.32M -20.7M -12.99M -14.38M -11.21M -13.44M -11.16M -13.3M -10.67M -8.08M -8.76M -14.32M
Capital Expenditures
n/a n/a n/a n/a -13K -29K -44K -8K n/a n/a -34K 8K -7K -242K -200K -74K -42K -24K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -47.28K 22.3K n/a n/a 14.51K 1.25K 15.97K n/a n/a n/a n/a n/a
Purchase of Investments
n/a -25.04M -119.35M n/a n/a -50.59M -5.02M -64.07M -182.83M -23.86M -48.01M -29.25M -38.04M -24.43M -19.72M -8.98M -40.8M -96.79M
Sales Maturities Of Investments
25.5M 27M 25M 31.75M 42.2M 58.62M 52.29M 41.77M 91.99M 51.79M 33.5M 28M 22.07M 34.16M 13.5M 13.5M 19.94M n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 8.03M 47.28K -22.3K -90.84K 27.93K -14.51K -1.25K -15.97K 9.73M -6.22M 4.52M -20.86M -96.79M
Investing Cash Flow
25.5M 1.96M -94.35M 31.75M 42.19M 8M 47.23M -22.31M -90.84M 27.93M -14.55M -1.24M -15.97M 9.49M -6.42M 4.44M -20.9M -96.82M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
252K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
72K 68K 304K 980K 399K n/a 175K 20K 489K -344K -138K -144K 124K n/a 16K 797K -1.59M -1.19M
Financial Cash Flow
324K 68K 304K 163.29M 399K n/a 13.86M 20K 489K 27.92M 106.23M 61.15M 124K n/a 16K 797K -1.59M 135.17M
Net Cash Flow
6.94M -22.42M -108.7M 178.64M 26.4M -14.83M 42.03M -43.03M -103.44M 41.12M 80.26M 46.17M -27.07M -3.82M -17.05M -2.84M -31.24M 23.98M
Free Cash Flow
-18.88M -24.44M -14.58M -16.45M -16.19M -22.83M -19.36M -20.71M -12.99M -14.38M -11.24M -13.43M -11.17M -13.54M -10.87M -8.16M -8.8M -14.34M